Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 195,200 | 111,700 | 86,600 | 38,100 | 60,100 |
| Depreciation Amortization | 152,800 | 115,800 | 76,100 | 38,800 | 168,100 |
| Income taxes - deferred | 15,900 | 7,700 | 5,700 | -700 | -24,300 |
| Accounts receivable | -33,600 | -58,400 | -56,200 | -19,100 | -12,900 |
| Accounts payable and accrued liabilities | 15,000 | 10,500 | 16,400 | 9,400 | 2,800 |
| Other Working Capital | -131,700 | -113,200 | -98,200 | -62,500 | -11,000 |
| Other Operating Activity | -12,600 | 87,100 | 64,500 | 16,900 | 49,600 |
| Operating Cash Flow | $201,000 | $161,200 | $94,900 | $20,900 | $232,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -102,500 | -62,200 | -40,900 | -16,300 | -105,300 |
| Net Acquisitions | N/A | N/A | N/A | -500 | -1,384,800 |
| Other Investing Activity | 206,600 | 0 | 0 | 0 | 105,500 |
| Investing Cash Flow | $104,100 | $-62,200 | $-40,900 | $-16,800 | $-1,384,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200 | -700 | -500 | -1,000 | 45,900 |
| Debt Issued | 241,200 | 188,700 | 65,900 | 23,000 | 1,438,400 |
| Debt Repayment | -632,800 | -364,600 | -177,300 | -75,300 | -571,900 |
| Common Stock Issued | 45,000 | 40,500 | 30,500 | 26,400 | 17,700 |
| Dividend Paid | -18,800 | -14,100 | -9,400 | -4,700 | -17,800 |
| Other Financing Activity | 10,800 | 9,300 | 7,300 | 5,800 | -6,500 |
| Financing Cash Flow | $-354,400 | $-140,900 | $-83,500 | $-25,800 | $905,800 |
| Exchange Rate Effect | 4,300 | 2,600 | 2,300 | 900 | -8,800 |
| Beginning Cash Position | 68,600 | 68,600 | 68,600 | 68,600 | 323,800 |
| End Cash Position | 23,600 | 29,300 | 41,400 | 47,800 | 68,600 |
| Net Cash Flow | $-45,000 | $-39,300 | $-27,200 | $-20,800 | $-255,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 201,000 | 161,200 | 94,900 | 20,900 | 232,400 |
| Capital Expenditure | -102,500 | -62,200 | -40,900 | -16,300 | -105,300 |
| Free Cash Flow | 98,500 | 99,000 | 54,000 | 4,600 | 127,100 |